Home > Annual Financials > KOPRAN

KOPRAN Financial Statement Analysis
[BOM: 524280|NSE : KOPRAN]

The Revenues of KOPRAN have decreased by -2.91% YoY .
The Earnings Per Share (EPS) of KOPRAN has decreased by -55.37 % YoY.
REVENUES
OPERATING MARGIN
PROFIT AFTER TAX
EPS
ROCE

KOPRAN Last 5 Annual Financial Results
[BOM: 524280|NSE : KOPRAN]

ConsolidatedMar2023
Mar2022
Mar2021
Mar2020
Mar2019
Revenues ₹478 Cr₹492 Cr₹359 Cr₹358 Cr₹313 Cr
Expenses ₹390 Cr₹410 Cr₹313 Cr₹312 Cr₹284 Cr
Operating Profit (Excl OI) ₹87 Cr₹82 Cr₹47 Cr₹45 Cr₹29 Cr
Other Income ₹11 Cr₹18 Cr₹0.63 Cr₹3.96 Cr₹11 Cr
Interest ₹5.12 Cr₹6.24 Cr₹8.91 Cr₹8.99 Cr₹8.60 Cr
Depreciation ₹11 Cr₹10 Cr₹9.58 Cr₹8.74 Cr₹8.51 Cr
Profit Before Tax ₹82 Cr₹83 Cr₹28 Cr₹32 Cr₹23 Cr
Profit After Tax ₹61 Cr₹62 Cr₹21 Cr₹24 Cr₹20 Cr
Consolidated Net Profit ₹61 Cr₹62 Cr₹21 Cr₹24 Cr₹20 Cr
Earnings Per Share (Rs)₹5.65₹12.66₹14.24₹4.86₹5.55
PAT Margin (%)4.8812.6012.295.816.71
ROE(%)6.2918.1928.3411.7415.34
ROCE(%)8.3021.4030.4013.6916.30
Total Debt/Equity(x)0.170.170.270.470.58

Key Financials

Market Cap : ₹ 1,280.0 Cr
Revenue (TTM) : ₹ 577.4 Cr
Net Profit(TTM) : ₹ 40.4 Cr
EPS (TTM) : ₹ 8.4
P/E (TTM) : 31.7

Industry Peers & Returns1W1M1Y
KOPRAN 15.6% -1.9% 154.6%
SUN PHARMACEUTICAL INDUSTRIES -0.8% 4% 61.6%
DIVIS LABORATORIES -2.1% -6% 26.4%
CIPLA 1.5% 3.3% 70.6%
DR REDDYS LABORATORIES 0.7% 0.4% 44.6%
TORRENT PHARMACEUTICALS -4% -2.8% 70.3%
ABBOTT INDIA 6% -3% 39.7%
ZYDUS LIFESCIENCES 0.3% 11.1% 109.1%
ALKEM LABORATORIES -1.5% -8.6% 63.1%


KOPRAN Revenues
[BOM: 524280|NSE : KOPRAN]

Y-o-Y

-2.91 %

5 Yr CAGR

11.11 %

Years Revenues % Change
Mar2023 ₹478 Cr
-2.91
Mar2022 ₹492 Cr
36.81
Mar2021 ₹359 Cr
0.45
Mar2020 ₹358 Cr
14.23
Mar2019 ₹313 Cr -


KOPRAN Operating Profit
[BOM: 524280|NSE : KOPRAN]

Y-o-Y

6.89 %

5 Yr CAGR

31.64 %

Years Operating Profit % Change
Mar2023 ₹87 Cr
6.89
Mar2022 ₹82 Cr
74.78
Mar2021 ₹47 Cr
2.78
Mar2020 ₹45 Cr
56.38
Mar2019 ₹29 Cr -

Operating Margins
Y-o-Y

10.13 %

5 Yr CAGR

18.49 %

Years Operating Margin% % Change
Mar2023 18.27%
10.13
Mar2022 16.59%
27.71
Mar2021 12.99%
2.36
Mar2020 12.69%
36.89
Mar2019 9.27% -

KOPRAN Profit After Tax
[BOM: 524280|NSE : KOPRAN]

Y-o-Y

-0.93 %

5 Yr CAGR

31.38 %

Years Profit After Tax % Change
Mar2023 ₹61 Cr
-0.93
Mar2022 ₹62 Cr
193.08
Mar2021 ₹21 Cr
-12.50
Mar2020 ₹24 Cr
17.27
Mar2019 ₹20 Cr -

PAT Margins
Y-o-Y

-61.27 %

5 Yr CAGR

-7.65 %

Years PAT Margin(%) % Change
Mar2023 4.88 %
-61.27
Mar2022 12.6 %
2.52
Mar2021 12.29 %
111.53
Mar2020 5.81 %
-13.41
Mar2019 6.71 % -

KOPRAN Earnings Per Share (EPS)
[BOM: 524280|NSE : KOPRAN]

Y-o-Y

-55.37 %

5 Yr CAGR

0.45 %

Years EPS % Change
Mar2023 ₹5.65
-55.37
Mar2022 ₹13
-11.10
Mar2021 ₹14
193.00
Mar2020 ₹4.86
-12.43
Mar2019 ₹5.55 -

KOPRAN Return on Capital Employed (ROCE)
[BOM: 524280|NSE : KOPRAN]

Y-o-Y

-61.21 %

5 Yr CAGR

-15.53 %

Years ROCE % Change
Mar2023 8.3%
-61.21
Mar2022 21.4%
-29.61
Mar2021 30.4%
122.06
Mar2020 13.69%
-16.01
Mar2019 16.3% -

KOPRAN Share Price vs Sensex

Current Share Price : ₹265.6
Current MarketCap: ₹ 1,280.0 Cr
Updated EOD on :Mar 18,2024

Share Price Returns(%) 1 Week 1 Month 1 Year
KOPRAN

15.6%

-1.9%

154.6%

SENSEX

-1%

1%

24.9%

KOPRAN related INDICES

BSE Indices1W1M1Y
S&P BSE HEALTHCARE -2.1% -2.4% 59.2%
S&P BSE ALLCAP -2.3% -1.4% 38%
S&P BSE MIDSMALLCAP -3.9% -5.5% 55.7%
S&P BSE SMALL CAP -4.1% -7.4% 53.4%
No NSE index found

You may also like the below Video Courses


FAQ about KOPRAN Financials


How the annual revenues of KOPRAN have changed ?

The Revenues of KOPRAN have decreased by -2.91% YoY .

How the Earnings per Share (EPS) of KOPRAN have changed?

The Earnings Per Share (EPS) of KOPRAN has decreased by -55.37 % YoY .